Immune responses to Leptospira infection: roles as biomarkers for disease severity

Abstract

Various leptospiral components have been identified and shown to be involved in tissue destruction. In addition, immune responses to leptospires have been implicated in target organ damages in severe leptospirosis cases. Several inflammatory mediators were shown to be higher in susceptible animals than in resistant hosts. Moreover, cytokines/chemokines and serum proteins induced following Leptospira infection were suggested to be biomarkers for disease severity in human leptospirosis. This review focuses on the role of immune responses in the severity of leptospirosis. Studies in both animal models and humans are discussed.

Leptospirosis; Severity; Biomarker; Immune response

Introduction

Leptospirosis is a worldwide zoonosis caused by spirochetes of genus Leptospira. Leptospirosis patients present with diverse clinical manifestations ranging from asymptomatic infection, mild infection with fever, headache, myalgia, dyspnea, to severe presentations involving multiple organs. Severe leptospirosis is characterized by jaundice, renal and hepatic failure.^1–3 In addition, pulmonary hemorrhage has been increasingly shown to be a cause of death of leptospirosis patients.⁴ Although the causative agent of leptospirosis was discovered since early 19th century,⁵ the pathogenetic mechanisms of this infectious disease are still not clearly understood. Several components of pathogenic Leptospira have been identified.^6–12 However, it is still not known why patients infected with pathogenic Leptospira present with diverse clinical manifestations.

The immune response to Leptospira is suggested to play a role in organ damages observed in Leptospira infection. Various inflammatory mediators and serum proteins were thought to be promising biomarkers for disease severity prediction. Several studies elicited immune response to leptospira by stimulating cells with Leptospira or Leptospira components in vitroor by injecting Leptospira components into animal models.^13–16 Although these experiments could elicit an immune response, these approaches may not mimic infection-induced of immune response. This review focuses mainly on studies of immune response induced by Leptospira infection. Studies conducted in animal models and in humans are reviewed.

To demonstrate the role of immune response in organ damage observed in infectious diseases, production of inflammatory cytokines, chemokines and adhesion molecules are commonly investigated. These mediators have also been suggested to play role in leptospirosis pathogenesis.

Immune responses in Leptospira infected animal models

Hamsters and guinea pigs are commonly used as susceptible animal models for leptospirosis. Pathologies and bacterial burden in target organs following Leptospirainfection were evaluated in these susceptible animals. Cytokine gene expression in blood from recovered and dead hamsters infected with leptospires has been reported.¹⁷ TNF-α, IL-10, IL-1α and COX-2 expression was significantly higher in dead hamsters than in the survivors. In addition, the expression of these cytokines was also higher in hamsters infected with virulent leptospires than in hamsters infected with an avirulent strain.

Mice are known to resist to Leptospira infection. Comparison of inflammatory mediators in hamsters and Oncins France 1 (OF1) resistant mice following Leptospira infection was reported. Infected hamsters demonstrated pathologies and bacterial burden in various organs. OF1 mice showed rapid Leptospiraclearance. Cytokine/chemokine gene expression was assessed in this study. Compared to resistant mice, hamsters showed delayed and massive expression of IL-1β, IL-6, TNF-α, cyclo-oxygenase -2, IP-10/CXCL10 and MIP-1α/CCL3 in infected organs. In addition, IL-10, an anti-inflammatory cytokine, was induced faster in infected resistant mice than in infected hamsters.¹⁸

Although mice are resistant to Leptospira infection, C3H/HeJ, the TLR4 defective mice, have been shown to be susceptible to Leptospira infection.¹⁹ Immune response induced by leptospires in resistant (BALB/C) and susceptible (C3H/HeJ) mice were compared.²⁰ Expressions of TNF-α and MIP-2/CXCL-2 in lungs, kidneys and livers of infected animals were determined by qPCR and ELISA. Expressions of TNF-α and CXCL-2 were delayed in C3H/HeJ mice. The sustained MCP-1 and IL-8 expression in lungs of infected C3H/HeJ was also shown.

The alteration of epithelial sodium channel (ENac) and Na-K-2Cl (NKCC) co-transporter expression in lungs of hamsters infected with Leptospira was reported. ENac expression was decreased whereas the expression of NKCC was increased in pulmonary cells of infected hamsters. This study suggested that alteration of ion channel following Leptospira infection may impair pulmonary function resulting in pulmonary damage observed in leptospirosis.²¹

It has been shown in vitro that TNF-α decreased ENac and IL-1 increased Na-K-2Cl co-transporter.^22–25 As mentioned earlier, TNF-α and IL-1 were increased in Leptospirainfection. These data suggest that these two cytokines could be involved in alteration of ion channels resulting in pulmonary damage.

Expression of TNF-α, TGF-β, IP-10 and IL-10 in kidneys of hamsters infected with Leptospira has been reported.²⁶ However, correlation of these cytokine expression and kidney damage is still not clearly demonstrated.

Immune responses in leptospirosis patients

Various studies demonstrated immune responses in human leptospirosis. Levels of T-cell chemoattractants, IP-10/CXCL10 and Mig/CXCL9 were higher in leptospirosis patients than in controls.²⁷ However, correlation of these chemokines with disease severity was not shown. The level of IL-8 was investigated in leptospiral hepatitis. IL-8 levels were significantly higher in leptospirosis patients than in controls and severe symptoms were also associated with high IL-8 levels.²⁸

Tajiki and Salomao in 1996 measured plasma level of TNF-α in 18 leptospirosis patients. They found TNF-α level to be related to kidney, liver and lung involvement.²⁹ This study suggested that TNF-α level could be a useful marker for poor prognosis. In addition, the ratio of plasma IL-10/TNF-α was determined in leptospirosis patients with and without organ involvement. In this study, a high IL-10/TNF-α ratio was associated with less disease severity.³⁰ In contrast, Kyriakidis et al. in 2011 investigated cytokine levels in 28 leptospirosis patients and found a high IL-10/TNFα ratio to be associated with fatal outcome.³¹

Expression of ICAM-1 (intercellular adhesion molecule-1), VCAM-1 (vascular cell adhesion molecule-1) and C3a receptor on lung tissues of leptospirosis patients was studied. Expression of ICAM-1, VCAM-1 and C3a receptor on alveolar septa of patients who died from leptospirosis with pulmonary involvement was higher than in control groups.³² The expression of these adhesion molecules and complement receptor could promote leukocyte recruitment to infected tissues.

Levels of other serum proteins such as ST2, long pentraxin-3 (PTX3) and copeptins have been investigated in leptospirosis patients. ST2 is a member of interleukin receptor family and a receptor for IL-33. Two ST2 isoforms including membrane (ST2L) and soluble ST2 (sST2) have been identified. Plasma ST2 level is increased in heart and inflammatory diseases.^33–36 PTX3 is an acute phase protein belonging to the pentraxin family. It is a mediator of inflammation and its expression is induced in various cell types.³⁷ Plasma PTX3 was shown to be a severity marker of inflammatory conditions and cardiovascular diseases.^38–41 Copeptin is a 39-amino acid peptide released from arginine vasopressin (AVP) during AVP processing. It has been suggested to be a biomarker for various conditions including bacterial sepsis.^42–44

Wagenaar et al. determined soluble ST2 (sST2), TNF-α, IL-1β, IL-6, IL-8 and IL-10 levels in 68 severe leptospirosis patients. This study suggested that sST2, IL-6 and IL-8 levels were higher in non-survivors than in survivors. In addition, sST2 level was associated with bleeding and suggested to be a tissue damage marker. In another study, IL-6, IL-8 and long pentraxin-3 (PTX3) levels in 52 leptospirosis patients were investigated. The mortality rate of this group of patients was 27%. This study demonstrated that PTX3, IL-6 and IL-8 levels were associated with disease severity and mortality.^45,46

Plasma copeptin level in leptospirosis patients has been suggested to be a predictor of survival. Among survivors, copeptin level decreased to baseline level within seven days.⁴⁷ Serum nitrite has also been shown to be increased in leptospirosis compared to healthy controls. However, correlation of serum nitrite with disease severity was not shown in this study.⁴⁸

Discussion

Increasing evidence indicate that immune response could enhance tissue damage observed in leptospirosis patients, especially in severe cases. As described above, both inflammatory and anti-inflammatory cytokines were induced by Leptospira infection. Moreover, chemokines participating in neutrophil and mononuclear cell recruitment were also produced.

TNF-α is a cytokine widely studied in immune-mediated diseases and is the most investigated cytokine in leptospirosis.^20,31,49 It is an inflammatory cytokine produced following toll-like receptor (TLR) stimulation.⁵⁰ C3H/HeJ mice are TLR-4 defective and were shown to be susceptible to Leptospira infection.¹⁹ However, correlation of TLR-4 mutation and leptospirosis pathogenesis is not clearly established.

Compared to infected BALB/C mice, TNF-α production in Leptospirainfected C3H/HeJ mice was delayed in one study.²¹ Similar result was observed when TNF-α gene expression was investigated in mice and hamsters infected with Leptospira. Experiment in C57BL/6 mice with knockout TNF-α receptors (TNFR) has been reported. Severe renal inflammation was observed in convalescent TNFR deficient mice. This study supported the role of rapid induction of TNF-α following Leptospira infection.⁵¹ In addition, TNF-α induction was shown to be higher in hamsters that did not die after experimental leptospiral infection.¹⁷

These data suggest that for bacterial eradication, inflammatory cytokines should be induced rapidly. Delayed expression may allow for bacterial colonization and multiplication. However, production of inflammatory cytokines should be properly regulated. Prolonged production could promote further tissue damage. Leptospira toxins could directly induce tissue damage which is further promoted by inflammatory response.

High IL-10/TNF-α ratio was shown to be associated with less disease severity in one study.³⁰ However, in another study, high IL-10/TNF-α ratio was associated with fatal outcome of leptospirosis patients.³¹ These data suggested the role of both inflammatory and anti-inflammatory cytokines in disease outcomes of leptospirosis. However, application of these two cytokines ratio as a disease marker needs to be further investigated in larger groups of patients.

IL-10 level was induced faster in infected BALB/C than in infected hamsters.¹⁸ The rapid production of this anti-inflammatory cytokine could regulate inflammatory cytokines production resulting in alleviation of tissue damage. Besides promoting inflammation, TNF-α could be involved in impairment of pulmonary function by altering epithelium sodium channel.^21,22 Role of TNF-α in sodium channel change in leptospirosis with pulmonary hemorrhage has not been directly reported.

Chemokine involvement has been widely investigated in leptospirosis. Induction of IL-8 was delayed and sustained in C3H/HeJ mice infected with leptospires than in the resistant mice.⁵² The association of IL-8 level and disease severity and mortality has been shown in leptospirosis patients.²⁸

In addition to cytokines and chemokines, other serum inflammatory mediators including sST2, PTX3 and copeptin were investigated whether they could be used as biomarkers for leptospirosis severity.

Conclusion

Fig. 1A and B are diagrams suggesting how host inflammatory responses participate in a wide range of leptospirosis symptoms. Various studies have shown that cytokines and serum proteins are promising biomarkers for leptospirosis severity. However, further studies should be done to confirm the reliability of these proteins in disease prediction. It would be interesting to investigate the levels of these suggested biomarkers in larger groups of patients with different degrees of leptospirosis illnesses. In addition, detection of inflammatory mediators should be performed using samples collected at various times after infection. The data obtained could confirm whether rapid or delayed production of inflammatory/anti-inflammatory mediators influences disease outcomes. Moreover, most studies investigated cytokines/chemokines levels in patient sera. In order to demonstrate whether immune responses participate in organ damage in leptospirosis, investigation of cytokines/chemokines levels in target organs should provide more convincing evidence.

Fig. 1
Diagrams suggesting how inflammatory responses involve in different disease outcomes of leptospirosis. (A) Leptospira infection in resistant animal models or in hosts with mild symptoms. Leptospira components or toxins could directly induce tissue damage. Infected hosts recognize Leptospira and respond aiming at eradicating these infectious agents. Inflammatory responses occur early and rapidly to eradicate organisms. Further tissue dissemination is prevented. Anti-inflammatory cytokines are produced to regulate inflammation. Finally, leptospires are eradicated and no or mild tissue damage is observed. (B) Leptospira infection in susceptible animal models or in hosts with severe symptoms. Leptospira components or toxins could directly induce tissue damage. There is no clear evidence demonstrating that different pathogenic Leptospira contain different virulence factors. Infected hosts recognize Leptospira and respond aiming at eradicating these infectious agents. However, in these hosts, inflammatory responses were delayed. Organisms persist and promote further inflammatory responses. The delay of Leptospira eradication may provide time for bacterial dissemination to various organs. These prolonged and massive immune response could promote further tissue damages resulting in severe organ damage observed in susceptible animals or hosts with severe clinical manifestations.

Genetic difference could play an important role in a wide range of clinical manifestations in leptospirosis patients. Mice with TLR4 defective are susceptible to infection.¹⁹ Although, there are increasing numbers of reports on Leptospira genes, there are a few studies on human genetics involving severe Leptospira infection. Single nucleotide polymorphisms in IL-4 and IL-4 receptor that had higher frequencies in leptospirosis patients were reported.⁵³ However, it has been shown that IL-4 deficiency had no effect on resistance of BALB/C mice to Leptospira infection.⁵¹

Finally, the number of leptospires that infect each patient and the virulence of the infecting leptospires could play a role in different outcomes following Leptospirainfection. However, currently, there is no report correlating leptospiral load and leptospirosis disease severity. In addition, disease outcomes in patients infected with pathogenic Leptospira with different degrees of virulence have not been compared.

Acknowledgements

Authors thank Rachadapiseksompoch research fund, Faculty of Medicine, Chulalongkorn University and the Higher Education Research Promotion and National Research University Project of Thailand (HR1155A), Office of the Higher Education Commission for the support of leptospirosis research.

REFERENCES

• ¹
  Vinetz JM. Leptospirosis. Curr Opin Infect Dis. 2001;14:527–38.
• ²
  Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14:296–326.
• ³
  Plank R, Dean D. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect. 2000;2:1265–76.
• ⁴
  Medeiros Fda R, Spichler A, Athanazio DA. Leptospirosis-associated disturbances of blood vessels, lungs and hemostasis. Acta Trop. 2010;115:155–62.
• ⁵
  Levett PN. Leptospira species (Leptospirosis). 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2009.
• ⁶
  Cullen PA, Haake DA, Adler B. Outer membrane proteins of pathogenic spirochetes. FEMS Microbiol Rev. 2004;28:291–318.
• ⁷
  Raman R, Rajanikanth V, Palaniappan RU, et al. Big domains are novel Ca⁽²⁾⁺-binding modules: evidences from big domains of Leptospiraimmunoglobulin-like (Lig) proteins. PLoS One. 2010;5:e14377.
• ⁸
  Vieira ML, Atzingen MV, Oliveira TR, et al. In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans PLoS One. 2010;5:e11259.
• ⁹
  Cesar KR, Romero EC, de Braganca AC, Blanco RM, Abreu PA, Magaldi AJ. Renal involvement in leptospirosis: the effect of glycolipoprotein on renal water absorption. PLoS One. 2012;7:e37625.
• ¹⁰
  Lee SH, Kim S, Park SC, Kim MJ. Cytotoxic activities of Leptospira interrogans hemolysin SphH as a pore-forming protein on mammalian cells. Infect Immun. 2002;70: 315–22.
• ¹¹
  de la Pena-Moctezuma A, Bulach DM, Kalambaheti T, Adler B. Comparative analysis of the LPS biosynthetic loci of the genetic subtypes of serovar Hardjo: Leptospira interrogans subtype Hardjoprajitno and Leptospira borgpetersenii subtype Hardjobovis. FEMS Microbiol Lett. 1999;177:319–26.
• ¹²
  Janwitthayanan W, Keelawat S, Payungporn S, et al. In vivo gene expression and immunoreactivity of Leptospira collagenase Microbiol Res. 2013;168:268–72.
• ¹³
  de Fost M, Hartskeerl RA, Groenendijk MR, van der Poll T. Interleukin 12 in part regulates gamma interferon release in human whole blood stimulated with Leptospira interrogans Clin Diagn Lab Immunol. 2003;10:332–5.
• ¹⁴
  Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect Immun. 2001;69:7550–8.
• ¹⁵
  Wang H, Wu Y, Ojcius DM, et al. Leptospiral hemolysins induce proinflammatory cytokines through Toll-like receptor 2-and 4-mediated JNK and NF-kappaB signaling pathways. PLoS One. 2012;7:e42266.
• ¹⁶
  Yan W, Faisal SM, McDonough SP, et al. Immunogenicity and protective efficacy of recombinant Leptospira immunoglobulin-like protein B (rLigB) in a hamster challenge model. Microbes Infect. 2009;11:230–7.
• ¹⁷
  Vernel-Pauillac F, Goarant C. Differential cytokine gene expression according to outcome in a hamster model of leptospirosis. PLoS Negl Trop Dis. 2010;4:e582.
• ¹⁸
  Matsui M, Rouleau V, Bruyere-Ostells L, Goarant C. Gene expression profiles of immune mediators and histopathological findings in animal models of leptospirosis: comparison between susceptible hamsters and resistant mice. Infect Immun. 2011;79:4480–92.
• ¹⁹
  Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–8.
• ²⁰
  da Silva JB, Carvalho E, Covarrubias AE, et al. Induction of TNF-alpha and CXCL-2 mRNAs in different organs of mice infected with pathogenic Leptospira Microb Pathog. 2012;52:206–16.
• ²¹
  Andrade L, Rodrigues Jr AC, Sanches TR, Souza RB, Seguro AC. Leptospirosis leads to dysregulation of sodium transporters in the kidney and lung. Am J Physiol Renal Physiol. 2007;292:F586–92.
• ²²
  Dagenais A, Frechette R, Yamagata Y, et al. Downregulation of ENaC activity and expression by TNF-alpha in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;286:L301–11.
• ²³
  Yamagata T, Yamagata Y, Nishimoto T, et al. The regulation of amiloride-sensitive epithelial sodium channels by tumor necrosis factor-alpha in injured lungs and alveolar type II cells. Respir Physiol Neurobiol. 2009;166:16–23.
• ²⁴
  Eisenhut M. Interleukin-1 and the constellation of pulmonary oedema, and cerebral infarctions and oedema in diabetic ketoacidosis. Diabet Med. 2006;23:1386.
• ²⁵
  Choi JY, Choi YS, Kim SJ, Son EJ, Choi HS, Yoon JH. Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells. Eur J Pharmacol. 2007;567:19–25.
• ²⁶
  Lowanitchapat A, Payungporn S, Sereemaspun A, et al. Expression of TNF-alpha, TGF-beta, IP-10 and IL-10 mRNA in kidneys of hamsters infected with pathogenic Leptospira Comp Immunol Microbiol Infect Dis. 2010;33:423–34.
• ²⁷
  De Fost M, Chierakul W, Limpaiboon R, Dondorp A, White NJ, van Der Poll T. Release of granzymes and chemokines in Thai patients with leptospirosis. Clin Microbiol Infect. 2007;13:433–6.
• ²⁸
  Rizvi M, Azam M, Ajmal MR, Shukla I, Malik A. Prevalence of leptospira in acute hepatitis syndrome and assessment of IL-8 and TNF-alpha level in leptospiral hepatitis. Ann Trop Med Parasitol. 2011;105:499–506.
• ²⁹
  Tajiki H, Salomao R. Association of plasma levels of tumor necrosis factor alpha with severity of disease and mortality among patients with leptospirosis. Clin Infect Dis. 1996;23:1177–8.
• ³⁰
  Tajiki MHSNA, Salomão R. The ratio of plasma levels of IL-10/TNF-alpha and its relationship to disease severity and survival in patients with leptospirosis. Braz J Infect Dis. 1997;1:138–41.
• ³¹
  Kyriakidis I, Samara P, Papa A. Serum TNF-alpha, sTNFR1, IL-6, IL-8 and IL-10 levels in Weil's syndrome. Cytokine. 2011;54:117–20.
• ³²
  Del Carlo Bernardi F, Ctenas B, da Silva LF, et al. Immune receptors and adhesion molecules in human pulmonary leptospirosis. Hum Pathol. 2012;43:1601–10.
• ³³
  Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479–90.
• ³⁴
  Kakkar R, Lee RT. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov. 2008;7:827–40.
• ³⁵
  Weinberg EO. ST2 protein in heart disease: from discovery to mechanisms and prognostic value. Biomark Med. 2009;3:495–511.
• ³⁶
  Miller AM, Liew FY. The IL-33/ST2 pathway—a new therapeutic target in cardiovascular disease. Pharmacol Ther. 2011;131:179–86.
• ³⁷
  Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol. 2005;23:337–66.
• ³⁸
  Kotooka N, Inoue T, Aoki S, Anan M, Komoda H, Node K. Prognostic value of pentraxin 3 in patients with chronic heart failure. Int J Cardiol. 2008;130:19–22.
• ³⁹
  Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 2009;29:594–9.
• ⁴⁰
  Luchetti MM, Piccinini G, Mantovani A, et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol. 2000;119:196–202.
• ⁴¹
  Mauri T, Bellani G, Patroniti N, et al. Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality. Intensive Care Med. 2010;36:621–9.
• ⁴²
  Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med. 2012;10:7.
• ⁴³
  Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal function. Congest Heart Fail. 2010;16 Suppl. 1:S37–44.
• ⁴⁴
  Morgenthaler NG, Struck J, Jochberger S, Dunser MW. Copeptin: clinical use of a new biomarker. Trends Endocrinol Metab. 2008;19:43–9.
• ⁴⁵
  Wagenaar JF, Gasem MH, Goris MG, et al. Soluble ST2 levels are associated with bleeding in patients with severe Leptospirosis. PLoS Negl Trop Dis. 2009;3:e453.
• ⁴⁶
  Wagenaar JF, Goris MG, Gasem MH, et al. Long pentraxin PTX3 is associated with mortality and disease severity in severe Leptospirosis. J Infect. 2009;58:425–32.
• ⁴⁷
  Limper M, Goeijenbier M, Wagenaar JF, et al. Copeptin as a predictor of disease severity and survival in leptospirosis. J Infect. 2010;61:92–4.
• ⁴⁸
  Gunaratna RI, Handunnetti SM, Bulathsinghalage MR, et al. Serum nitrite levels in Sri Lankan patients with leptospirosis. Asian Pac J Trop Med. 2012;5:75–8.
• ⁴⁹
  Estavoyer J, Racadot E, Couetdic G, Leroy J, Grosperrin L. Tumor necrosis factor in patients with leptospirosis. Rev Infect Dis. 1991;13:1245–6.
• ⁵⁰
  Togbe D, Schnyder-Candrian S, Schnyder B, et al. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol. 2007;88:387–91.
• ⁵¹
  Athanazio DA, Santos CS, Santos AC, McBride FW, Reis MG. Experimental infection in tumor necrosis factor alpha receptor, interferon gamma and interleukin 4 deficient mice by pathogenic Leptospira interrogans Acta Trop. 2008;105:95–8.
• ⁵²
  da Silva JB, Ramos TM, de Franco M, et al. Chemokines expression during Leptospira interrogans serovar Copenhageni infection in resistant BALB/c and susceptible C3H/HeJ mice. Microb Pathog. 2009;47(2):87–93.
• ⁵³
  Fialho RN, Martins L, Pinheiro JP, et al. Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis. Hum Immunol. 2009;70:915–20.

Publication Dates

• Publication in this collection
  Jan-Feb 2014

History

• Received
  16 June 2013
• Accepted
  27 Aug 2013